Curis to Participate in Upcoming Investor Conferences
Get Alerts CRIS Hot Sheet
Join SI Premium – FREE
LEXINGTON, Mass., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced that the Company will participate at the following upcoming conferences:
- FBR Second Annual Healthcare Conference. Company management will participate in one-on-one investor meetings throughout the day on September 9, 2015, at the conference venue in Boston.
- Baird 2015 Healthcare Conference. Dr. Ali Fattaey, President and Chief Executive Officer, will present on September 10, 2015, at 1:25 p.m. Eastern Time in New York City. The company also will conduct one-on-one meetings with investors throughout the day. A corresponding live webcast of the presentation can be accessed by visiting:
http://wsw.com/webcast/baird43/cris
The webcast will be archived shortly after the live event and available for 30 days following the conference, and also available for 30 days on the Investor Relations section of the Curis website at www.curis.com.
About Curis, Inc.
Curis is a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, including its lead development candidate, CUDC-907, a dual HDAC and PI3K inhibitor that is being investigated in two clinical studies in patients with lymphomas and solid tumors. Curis is also engaged in a broad collaboration with Aurigene in the areas of immuno-oncology and precision oncology. Curis is also party to a collaboration with Genentech, a member of the Roche Group, under which Genentech and Roche are developing and commercializing Erivedge® for the treatment of advanced basal cell carcinoma.
For more information, visit Curis' website at www.curis.com.
CONTACT: For More Information: Mani Mohindru, Ph.D. Senior Vice President, Corporate Strategy and Investor Relations Curis, Inc. 617-503-6605 [email protected] Media Contact David Schull Russo Partners (212) 845-4271 [email protected]Source: Curis, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- T2EARTH Launches Official YouTube Channel – T2EARTH Talks
- Bragar Eagel & Squire, P.C. Is Investigating CI&T, Harbor, AXTI, and Morgan Stanley and Encourages Investors to Contact the Firm
- Armenian Political Prisoner Initiates Hunger Strike in Baku, According to Free Armenian Prisoners
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!